Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-037127

Options or other derivatives

  • Director acquired 17,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Brege Laura Director 2023-06-12 Grant or award · Stock Option (right to buy) +17,000 17,000 D: show line 1 in the form
Loading xslF345X04/doc4.xml…